Showing results (241-250 of 274) with videos related to

Sort By:
Pageof 28
Annals of Hematology|April 19, 2022
Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variantYi Wang, Tingyu Wang, Ying Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2018
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple MyelomaYan Xu, Shuhui Deng, Xuehan Mao, et al.
Science Advances|June 5, 2021
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironmentJiye Liu, Teru Hideshima, Lijie Xing, et al.
Frontiers in Immunology|May 26, 2023
Minimal residual disease status improved the response evaluation in patients with Waldenström's macroglobulinemiaWenjie Xiong, Zanzan Wang, Tingyu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2024
Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)Huishou Fan, Bing Wang, Lihui Shi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2022
Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple MyelomaXiangling Feng, Jiaojiao Guo, Gang An, et al.
Leukemia & Lymphoma|December 18, 2019
1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomibChenxing Du, Xuehan Mao, Yan Xu, et al.
The Oncologist|March 10, 2025
Classification of NK-large granular lymphocytic leukemia by CD56 expressionYuxi Li, Rui Cui, Ying Yu, et al.
Nature Communications|July 11, 2022
Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balanceJiliang Xia, Jingyu Zhang, Xuan Wu, et al.
Journal for Immunotherapy of Cancer|September 13, 2022
Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myelomaXiaoyan Qu, Gang An, Weiwei Sui, et al.
Pageof 28